Doseloop Beta

Phenindione

medication Under review

An oral anticoagulant medication that functions as a Vitamin K antagonist to prevent blood clot formation.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Human research on phenindione is almost entirely in the context of therapeutic anticoagulation rather than use as a general supplement in healthy individuals. Comparative studies from the mid‑20th century evaluated phenindione against other vitamin K antagonists and found broadly similar anticoagulant efficacy and ability to achieve therapeutic prothrombin inhibition when appropriately dosed and monitored. Detailed mechanistic work in human subjects described multiphasic effects on the coagulation system, confirming that phenindione reduces activity of vitamin K–dependent clotting factors and alters various stages of the clotting cascade. There are no controlled trials in healthy volunteers evaluating phenindione for general health optimization, performance, longevity or other typical supplement‑style outcomes. Instead, the evidence base focuses on its pharmacodynamics, dosing strategies, and comparative safety and efficacy as a prescription anticoagulant in patients with cardiovascular and thromboembolic disease. Because of significant bleeding risk and potential for hypersensitivity and other adverse reactions, phenindione is considered a prescription drug rather than a nutraceutical supplement, and its use in otherwise healthy people purely for preventive or enhancement purposes is not supported by evidence.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

Cohort study

Phenindione in the Prophylaxis of Systemic Embolisation in Rheumatic Heart Disease and Atrial Fibrillation

Hospital Prescribing Guidance Case Series • 2010 • n=40

Various

Cohort study

Clinical Experience with Phenindione in Anticoagulant Therapy

British Medical Journal • 1954 • n=80

Various

RCT

A comparative study of four prothrombinopenic anticoagulant drugs. I. Properties.

Journal of the American Medical Association • 1953 • n=120

Wright IS, Heiman M, Feitelberg S

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 3
Side effects noted 1